Jason Laine

Minnesota Pilot Trial Tests State Cannabis Program as a Research Pathway in Advanced Pancreatic Cancer 0
- MEDICAL MARIJUANA
- November 3, 2026
A pilot randomized trial in Minnesota tested whether a state medical cannabis program can support clinical research, according to a study in JCO Oncology Practice. The waitlist-controlled trial enrolled 32 patients with newly diagnosed advanced pancreatic cancer, randomized to early access (weeks 0–8) or delayed access (weeks 9–16) through the Minnesota Medical Cannabis Program. The
READ MORE
Pilot Trial Tests 1:1 THC:CBD Cannabis Oil in Adults With Fibromyalgia 0
- CANNABIS OIL
- October 27, 2026
A small Australian pilot trial has reported preliminary results for a 1:1 THC:CBD cannabis oil in adults with fibromyalgia, published in Pain Research and Management. Twenty-four adults were randomised to the oil or placebo for 16 weeks; 22 completed the study. The trial’s main aims were feasibility and safety, and adverse events were mostly mild,
READ MORE

Penn State Survey Finds Most Cancer Patients Who Used Cannabis Reported Symptom Relief 0
- MEDICAL MARIJUANA
- October 20, 2026
About a quarter of cancer patients surveyed at the Penn State Cancer Institute had used cannabis since their diagnosis, and most of those users reported improvement in symptoms including insomnia, appetite, mood and cancer-related pain, according to a study published in Supportive Care in Cancer on October 9. Of 186 patients who completed an anonymous
READ MORE
Phase 2 Trial Finds Cannabis Oil No Better Than Placebo for Parkinson’s Disease Pain 0
- CANNABIS OIL
- October 13, 2026
A phase 2 randomized trial in Brazil found that an oral CBD-dominant cannabis oil did not reduce chronic pain in people with Parkinson’s disease more than placebo, according to a NeurologyLive report on the study, published in Movement Disorders. Of 101 adults randomized, 87 completed the nine-week trial, which stopped early after a planned futility
READ MORE

Cannabionews